FOLD icon

Amicus Therapeutics

202 hedge funds and large institutions have $2.66B invested in Amicus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 70 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

4% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 70

9% less funds holding

Funds holding: 223202 (-21)

39% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 49

Holders
202
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.5M
Puts
$4.36M
Net Calls
Net Calls Change

Top Buyers

1 +$57.7M
2 +$36.8M
3 +$34.7M
4
DM
Deerfield Management
New York
+$30.1M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$25.6M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$384K
127
$354K
128
$353K
129
$351K
130
$330K
131
$325K
132
$323K
133
$323K
134
$322K
135
$295K
136
$278K
137
$250K
138
$221K
139
$218K
140
$209K
141
$207K
142
$206K
143
$201K
144
$196K
145
$193K
146
$185K
147
$178K
148
$174K
149
$169K
150
$168K